Neovasc Inc (NVCN)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Neovasc Inc (NVCN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011215
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neovasc Inc (Neovasc) is a medical device company that develops, manufactures and sells products for cardiovascular disease. The company offers products such as tiara, reducer and tissue products. Its tiara is a novel transcatheter device that is designed for treating mitral regurgitation, a condition that is often severe and can lead to heart failure and death. Neovasc’s reducer is used for the treating refractory angina. The company’s reducer procedure uses standard catheter-based techniques. It operates in Canada and the US. Neovasc is headquartered in Richmond, British Columbia, Canada.

Neovasc Inc (NVCN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Neovasc Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Neovasc Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Neovasc Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Neovasc Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Neovasc Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Neovasc Inc, Medical Equipment, Deal Details 11
Equity Offering 11
Neovasc Raises USD37.5 Million in Public Offering of Units 11
Neovasc Raises USD75 Million in Public Offering of Shares 13
Neovasc Completes Public Offering Of Shares For US$22.7 Million 14
Neovasc Completes Private Placement Of Shares For US$2.2 Million Upon Exercise Of Warrants 15
Neovasc Completes Non-Brokered Private Placement Of Units For US$5 Million 16
Debt Offering 18
Neovasc Raises USD27.83 Million in Private Placement of Notes Due 2018 and Warrants 18
Asset Transactions 19
Boston Scientific Acquires Tissue Processing Technology and Facility from Neovasc for USD68 Million 19
LeMaitre Vascular Finalizes Acquisition of XenoSure From Neovasc For US$5 Million 20
Acquisition 22
Boston Scientific Acquires 15% Stake in Neovasc for USD7 Million 22
Fidelity Acquires 30% Stake in Neovasc from Peregrine Ventures 24
Neovasc Inc – Key Competitors 25
Neovasc Inc – Key Employees 26
Neovasc Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Financial Announcements 28
Nov 14, 2017: Neovasc Announces Results for the Third Quarter of 2017 28
Aug 10, 2017: Neovasc Announces Results for the Second Quarter of 2017 31
May 10, 2017: Neovasc Announces Results for the First Quarter of 2017 34
Mar 23, 2017: Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2016 36
Nov 14, 2016: Neovasc Reports Third Quarter Results for 2016 39
Aug 09, 2016: Neovasc Reports Second Quarter Results for 2016 41
Apr 29, 2016: Neovasc Reports First Quarter Results for 2016 44
Mar 29, 2016: Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2015 47
Legal and Regulatory 50
Nov 03, 2017: Neovasc Provides Litigation Update 50
Mar 10, 2017: Neovasc Announces TSX Symbol Change to NVCN 51
Jan 18, 2017: Neovasc Announces Update in Litigation with CardiAQ 52
Jul 05, 2016: Neovasc Receives NASDAQ Notification Regarding Minimum Bid Requirements 53
May 19, 2016: Neovasc Announces Jury Verdict in Litigation Brought by CardiAQ 54
Product News 55
01/11/2016: Neovasc Receives FDA Approval to add 40mm Valve Size to the TIARA-I Clinical Trial 55
Product Approvals 56
Jan 11, 2016: Neovasc Receives FDA Approval to add 40mm Valve Size to the TIARA-I Clinical Trial 56
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57

List of Tables
Neovasc Inc, Medical Equipment, Key Facts, 2016 2
Neovasc Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Neovasc Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Neovasc Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Neovasc Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Neovasc Inc, Deals By Market, 2011 to YTD 2017 9
Neovasc Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Neovasc Raises USD37.5 Million in Public Offering of Units 11
Neovasc Raises USD75 Million in Public Offering of Shares 13
Neovasc Completes Public Offering Of Shares For US$22.7 Million 14
Neovasc Completes Private Placement Of Shares For US$2.2 Million Upon Exercise Of Warrants 15
Neovasc Completes Non-Brokered Private Placement Of Units For US$5 Million 16
Neovasc Raises USD27.83 Million in Private Placement of Notes Due 2018 and Warrants 18
Boston Scientific Acquires Tissue Processing Technology and Facility from Neovasc for USD68 Million 19
LeMaitre Vascular Finalizes Acquisition of XenoSure From Neovasc For US$5 Million 20
Boston Scientific Acquires 15% Stake in Neovasc for USD7 Million 22
Fidelity Acquires 30% Stake in Neovasc from Peregrine Ventures 24
Neovasc Inc, Key Competitors 25
Neovasc Inc, Key Employees 26
Neovasc Inc, Subsidiaries 27

★海外企業調査レポート[Neovasc Inc (NVCN)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ASUSTeK Computer Inc.:企業の戦略・SWOT・財務情報
    ASUSTeK Computer Inc. - Strategy, SWOT and Corporate Finance Report Summary ASUSTeK Computer Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Puma Biotechnology Inc (PBYI):製薬・医療:M&Aディール及び事業提携情報
    Summary Puma Biotechnology Inc (Puma) is a biopharmaceutical company that develops novel therapeutics for the treatment of cancer. The company develops and commercializes three drug candidates, namely, PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357. Its pipeline portfolio also enc …
  • MSIG Insurance (Singapore) Pte. Ltd.:企業の戦略・SWOT・財務情報
    MSIG Insurance (Singapore) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary MSIG Insurance (Singapore) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Heliatek GmbH:電力:M&Aディール及び事業提携情報
    Summary Heliatek GmbH (Heliatek) is a solar energy company that manufactures and constructs organic photovoltaics. The company manufactures modules on flexible substrates utilizing a roll-to-roll production process. Its products include OPV oligomers, OPV polymers, and OPV dye-sensitized solar cells …
  • Blueprint Medicines Corp (BPMC)-医療機器分野:企業M&A・提携分析
    Summary Blueprint Medicines Corp (Blueprint) is a biotechnology company that develops drugs for the treatment of cancers. The company discovers selective kinase inhibitors for genomically defined cancer subsets. Its pipeline products include BLU-285, for treatment resistant gastrointestinal stromal …
  • Covanta Holding Corporation
    Covanta Holding Corporation - Strategy, SWOT and Corporate Finance Report Summary Covanta Holding Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Biocurv Medical Instruments, Inc.:企業の戦略・SWOT・財務情報
    Biocurv Medical Instruments, Inc. - Strategy, SWOT and Corporate Finance Report Summary Biocurv Medical Instruments, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Edinburgh Bioquarter:製薬・医療:M&Aディール及び事業提携情報
    Summary Edinburgh Bioquarter (BioQuarter) is an academic medical center that offers translational medicine research services. The center develops new treatments for human and animal diseases by creating new drugs, diagnostic tools and medical devices. It conducts research in the field of regenerativ …
  • Ocean Spray Cranberries Inc:企業の戦略・SWOT・財務情報
    Ocean Spray Cranberries Inc - Strategy, SWOT and Corporate Finance Report Summary Ocean Spray Cranberries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Southwire Company, LLC:企業の戦略・SWOT・財務情報
    Southwire Company, LLC - Strategy, SWOT and Corporate Finance Report Summary Southwire Company, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cleanup Corporation (7955):企業の財務・戦略的SWOT分析
    Cleanup Corporation (7955) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Sanofi (SAN)-製薬・医療分野:企業M&A・提携分析
    Summary Sanofi is a healthcare company, which focuses on the research, development, manufacture and marketing a wide range of medicines and vaccines. Its product portfolio includes medicines for the treatment of cancer, diabetes, rare diseases, multiple sclerosis and cardiovascular diseases; human v …
  • Nippon Flour Mills Co., Ltd.
    Nippon Flour Mills Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Flour Mills Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • MarketSource Inc:企業の戦略的SWOT分析
    MarketSource Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (874):企業の財務・戦略的SWOT分析
    Summary Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (Guangzhou Baiyunshan Pharmaceutical) is a manufacturer of herbal medicine, chemical raw material medicine and preparation, biological medicine, and health products. The company also offers health medicines, health beverages, Chinese and we …
  • Air Liquide Welding France, S.A.:企業の戦略・SWOT・財務情報
    Air Liquide Welding France, S.A. - Strategy, SWOT and Corporate Finance Report Summary Air Liquide Welding France, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Actavalon Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Actavalon Inc (Actavalon) is an oncology-focused company, which develops small molecule medicines targeting two basic cancer pathways, namely, the p53 tumor suppressor pathway and the aryl hydrocarbon receptor (AhR) pathway. It is developing small molecules that can stabilize the mutant p53 …
  • Medica Corp:医療機器:M&Aディール及び事業提携情報
    Summary Medica Corp (Medica) is a medical device company that manufactures and markets in-vitro diagnostic blood testing analyzers. The company’s products comprise clinical chemistry analyzers, electrolyte analyzers, blood gas analyzers, and hematology analyzers, and OEM ISE modules. Medica’s produc …
  • Anhui Conch Cement Co Ltd:企業の戦略・SWOT・財務分析
    Anhui Conch Cement Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Anhui Conch Cement Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • PT. Indonesia Power:企業の戦略的SWOT分析
    PT. Indonesia Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆